Drug Shortage Report for LOVENOX
Report ID | 136137 |
Drug Identification Number | 02236883 |
Brand name | LOVENOX |
Common or Proper name | Lovenox |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-12-17 |
Actual start date | |
Estimated end date | 2021-12-20 |
Actual end date | 2021-12-02 |
Shortage status | Avoided shortage |
Updated date | 2021-12-02 |
Company comments | Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2021-06-15 | French | Compare |
v22 | 2021-06-22 | English | Compare |
v23 | 2021-06-22 | French | Compare |
v24 | 2021-06-22 | English | Compare |
v25 | 2021-06-22 | French | Compare |
v26 | 2021-06-22 | English | Compare |
v27 | 2021-06-22 | French | Compare |
v28 | 2021-07-13 | English | Compare |
v29 | 2021-07-13 | French | Compare |
v30 | 2021-07-23 | English | Compare |
v31 | 2021-07-23 | French | Compare |
v32 | 2021-08-31 | English | Compare |
v33 | 2021-08-31 | French | Compare |
v34 | 2021-09-21 | English | Compare |
v35 | 2021-09-21 | English | Compare |
v36 | 2021-09-21 | French | Compare |
v37 | 2021-09-21 | English | Compare |
v38 | 2021-09-21 | French | Compare |
v39 | 2021-09-30 | English | Compare |
v40 | 2021-09-30 | French | Compare |